AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33561312 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab 10 mg/kg
Number of subjects: 88
Study 32732500 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 15
Study 32732500 — intervention group
Group type: COMPARATOR
Intervention: No TXA (Control)
Number of subjects: 15
Study 36074560 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieving Self‐directed Integrated Cancer Aftercare (ASICA)
Number of subjects: 240
Study 36074560 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 240
Study 33106183 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose Interferon beta-1a + lopinavir/ritonavir (Kaletra)
Number of subjects: 100
Study 33106183 — intervention group
Group type: COMPARATOR
Intervention: Low dose Interferon beta-1a + lopinavir/ritonavir (Kaletra)
Number of subjects: 100
Study 33596972 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based alcohol reduction intervention
Number of subjects: 200
Study 33596972 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care control condition
Number of subjects: 200
Study 32339169 — intervention group
Group type: EXPERIMENTAL
Intervention: Capacitive resistive radiofrequency therapy (RF)
Number of subjects: 60
Study 32339169 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RF)
Number of subjects: 60
Study 35395957 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine, twice daily for 14 days
Number of subjects: 300
Study 35395957 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir, twice daily for 14 days
Number of subjects: 300
Study 35395957 — intervention group
Group type: COMPARATOR
Intervention: Placebo, twice daily for 14 days
Number of subjects: 300
Study 34082801 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet manioc starch (SMS)
Number of subjects: 11
Study 34082801 — intervention group
Group type: COMPARATOR
Intervention: Uncooked cornstarch (UCCS)
Number of subjects: 11
Study 32787925 — intervention group
Group type: EXPERIMENTAL
Intervention: Directly observed therapy (DOT)
Number of subjects: 1656
Study 32787925 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered therapy (SAT)
Number of subjects: 1656
Study 32787925 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed patient choice of either DOT or SAT
Number of subjects: 1656
Study 32787925 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of three strategies for delivering 3HP
Number of subjects: 1656
Study 36271391 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqua Stretch
Number of subjects: 40
Study 36271391 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqua Pilates
Number of subjects: 40
Study 36271391 — intervention group
Group type: COMPARATOR
Intervention: Control (routine drug treatment: NSAIDs & Anti TNF)
Number of subjects: 40
Study 33236188 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial recognition technology (Noldus FaceReader 7)
Number of subjects: 12
Study 33236188 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-point Sjövall hedonic scale
Number of subjects: 12
Study 33236188 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-point TASTY hedonic scale
Number of subjects: 12
Study 33236188 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-point TASTY hedonic scale
Number of subjects: 12
Study 33236188 — intervention group
Group type: EXPERIMENTAL
Intervention: Hedonic scales (5-point and 3-point)
Number of subjects: 12
Study 32423348 — intervention group
Group type: COMPARATOR
Intervention: Fruit-and-vegetable diet
Number of subjects: 326
Study 32423348 — intervention group
Group type: COMPARATOR
Intervention: DASH diet
Number of subjects: 326
Study 32423348 — intervention group
Group type: EXPERIMENTAL
Intervention: Control diet
Number of subjects: 326
Study 35979048 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychological intervention based on PERMA model
Number of subjects: 120
Study 33515503 — intervention group
Group type: EXPERIMENTAL
Intervention: Rucaparib 600 mg twice a day orally for six cycles of 28 days or until disease progression, unacceptable toxicity, withdrawal of consent, or death.
Number of subjects: 26
Study 33515503 — intervention group
Group type: EXPERIMENTAL
Intervention: Rucaparib
Number of subjects: 26
Study 35059823 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic debridement of dorsal capsule injuries during primary surgery
Number of subjects: 42
Study 35059823 — intervention group
Group type: COMPARATOR
Intervention: No debridement of dorsal capsule injuries during primary surgery
Number of subjects: 42
Study 34059327 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirogabalin 10 mg BID
Number of subjects: 1587
Study 34059327 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirogabalin 15 mg BID
Number of subjects: 1587
Study 34059327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1587
Study 32576202 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated cancer screening and prevention clinical decision support (CDS) and shared decision-making tools (SDMT)
Number of subjects: 0
Study 32576202 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted SDMT
Number of subjects: 0
Study 32576202 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer prevention CDS
Number of subjects: 0
Study 33779532 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher violence
Number of subjects: 643
Study 33779532 — intervention group
Group type: EXPERIMENTAL
Intervention: Internalizing problems
Number of subjects: 643
Study 33779532 — intervention group
Group type: EXPERIMENTAL
Intervention: Externalizing problems
Number of subjects: 643
Study 33572546 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (5 mg/kg)
Number of subjects: 60
Study 33572546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34402995 — intervention group
Group type: EXPERIMENTAL
Intervention: SPARK Child Mentoring program
Number of subjects: 94
Study 34402995 — intervention group
Group type: COMPARATOR
Intervention: Control group (students who did not receive the intervention)
Number of subjects: 94
Study 32196954 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetirizine oral disintegrating tablet (ODT) 5 mg
Number of subjects: 72
Study 32196954 — intervention group
Group type: COMPARATOR
Intervention: Levocetirizine immediate-release tablet (IRT) 5 mg
Number of subjects: 72
Study 35872697 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin plus intensive exercise diet therapy
Number of subjects: 120
Study 35872697 — intervention group
Group type: COMPARATOR
Intervention: Metformin (control group)
Number of subjects: 120
Study 32061833 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver‐oncologist therapeutic alliance (The Human Connection scale, modified into five items)
Number of subjects: 97
Study 32061833 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver anxiety (Generalized Anxiety Disorder‐7)
Number of subjects: 97
Study 36544634 — intervention group
Group type: EXPERIMENTAL
Intervention: ACP gel
Number of subjects: 200
Study 36544634 — intervention group
Group type: COMPARATOR
Intervention: Control (nothing)
Number of subjects: 200
Study 34853107 — intervention group
Group type: EXPERIMENTAL
Intervention: Care by a CCP physician who serves as a PCP across both inpatient and outpatient settings
Number of subjects: 24
Study 34853107 — intervention group
Group type: COMPARATOR
Intervention: Care by a PCP as outpatient and by hospitalists as inpatients (standard care)
Number of subjects: 24
Study 33745372 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroanimation therapy (NAT)
Number of subjects: 24
Study 33745372 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional occupational therapy (COT)
Number of subjects: 24
Study 33745372 — intervention group
Group type: COMPARATOR
Intervention: Neuroanimation therapy (NAT) and Conventional occupational therapy (COT) combined
Number of subjects: 24
Study 33122315 — intervention group
Group type: EXPERIMENTAL
Intervention: Periconceptional surveillance and biomarker survey for anaemia and micronutrient deficiencies
Number of subjects: 0
Study 33122315 — intervention group
Group type: EXPERIMENTAL
Intervention: Periconceptional surveillance
Number of subjects: 0
Study 35421224 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain version of the BART
Number of subjects: 254
Study 35421224 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss version of the BART
Number of subjects: 254
Study 35752521 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid with phenylephrine and lidocaine
Number of subjects: 240
Study 35752521 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine and lidocaine
Number of subjects: 240
Study 34346137 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined metformin and clomiphene citrate
Number of subjects: 0
Study 34346137 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic ovarian diathermy
Number of subjects: 0
Study 35357753 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% metformin cream
Number of subjects: 40
Study 35357753 — intervention group
Group type: COMPARATOR
Intervention: Triple combination cream (Kligman's formula)
Number of subjects: 40
Study 33512462 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative and hospice care integration for female veterans
Number of subjects: 19
Study 33512462 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospective chart reviews
Number of subjects: 19
Study 33512462 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective study designs
Number of subjects: 19
Study 32019855 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 341872
Study 32019855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341872
Study 33971913 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-based conversation aid
Number of subjects: 43
Study 33971913 — intervention group
Group type: EXPERIMENTAL
Intervention: Picture-based conversation aid
Number of subjects: 43
Study 33971913 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conversation aids
Number of subjects: 43
Study 34217079 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyphosate 7.2 g a.e. ha−1 in winter season
Number of subjects: 0
Study 34217079 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyphosate 36.0 g a.e. ha−1 in winter season
Number of subjects: 0
Study 34217079 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyphosate 1.8 g a.e. ha−1 in winter season
Number of subjects: 0
Study 34217079 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyphosate 12 g a.e. ha−1 in wet season
Number of subjects: 0
Study 33370164 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended family-based childhood obesity management program (10 weeks of in-person and online support)
Number of subjects: 0
Study 33370164 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study 32126989 — intervention group
Group type: EXPERIMENTAL
Intervention: Seasonal malaria chemoprevention (SMC) implemented in health sub-districts
Number of subjects: 6638
Study 32126989 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SMC)
Number of subjects: 6638
Study 35383101 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 100
Study 35383101 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 100
Study 32739224 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology (performed for one week, three times a week, 30 min before dressing change)
Number of subjects: 66
Study 32739224 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 66
Study 35770127 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital first aid nursing based on network information sharing platform
Number of subjects: 78
Study 35770127 — intervention group
Group type: COMPARATOR
Intervention: Routine first aid nursing
Number of subjects: 78
Study 33734452 — intervention group
Group type: EXPERIMENTAL
Intervention: THY1773 (10 mg/day to 110 mg/day)
Number of subjects: 0
Study 33734452 — intervention group
Group type: EXPERIMENTAL
Intervention: THY1773 (TS-121 capsule)
Number of subjects: 0
Study 33734452 — intervention group
Group type: EXPERIMENTAL
Intervention: THY1773 (in phase 1 RO study using PET)
Number of subjects: 0
Study 32772571 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Anticoagulation (OAC)
Number of subjects: 78
Study 32772571 — intervention group
Group type: COMPARATOR
Intervention: Antiplatelet Therapy (APT)
Number of subjects: 78
Study 32772571 — intervention group
Group type: COMPARATOR
Intervention: Device-related thrombosis
Number of subjects: 78
Study 32772571 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous echocardiography contrast pre-LAAC
Number of subjects: 78
Study 33588768 — intervention group
Group type: EXPERIMENTAL
Intervention: Assistive technology and telecare
Number of subjects: 20
Study 33588768 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 20
Study 34098040 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health application (Zamplo) used for 24 weeks
Number of subjects: 0
Study 34098040 — intervention group
Group type: COMPARATOR
Intervention: EXCEL only control group
Number of subjects: 0
Study 32888712 — intervention group
Group type: EXPERIMENTAL
Intervention: Side-to-side cavocavostomy
Number of subjects: 290
Study 32888712 — intervention group
Group type: COMPARATOR
Intervention: Traditional piggyback implantation
Number of subjects: 290
Study 2004897541 — intervention group
Group type: EXPERIMENTAL
Intervention: AR‐paretic arm training (augmented-reality-based training)
Number of subjects: 19
Study 2004897541 — intervention group
Group type: COMPARATOR
Intervention: Control period (only regular therapy)
Number of subjects: 19
Study 35410548 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental contrasting of a negative future with a positive reality
Number of subjects: 0
Study 35410548 — intervention group
Group type: EXPERIMENTAL
Intervention: Vicarious mental contrasting
Number of subjects: 0
Study 35410548 — intervention group
Group type: COMPARATOR
Intervention: Negative fantasizing
Number of subjects: 0
Study 32108399 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I - without any protective or monitoring dispositive, limiting RF applications to 30 W for 20 seconds at left atrium posterior wall (LAPW)
Number of subjects: 45
Study 32108399 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II - power and time of RF delivery, up to 50 W for 20 seconds at LAPW, limited by esophageal temperature monitoring
Number of subjects: 45
Study 32108399 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III - applications of RF in LAPW with fixed power application of 50 W for 20 seconds during continuous esophageal cooling
Number of subjects: 45
Study 35379593 — intervention group
Group type: EXPERIMENTAL
Intervention: COPe-support (digital psychoeducation and peer support)
Number of subjects: 407
Study 35379593 — intervention group
Group type: COMPARATOR
Intervention: Passive online information resource (control)
Number of subjects: 407
Study 34538275 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-guided heparinization (100 IU/kg bolus of heparin with ACT measurements)
Number of subjects: 750
Study 34538275 — intervention group
Group type: COMPARATOR
Intervention: 5000 IU of heparin (no ACT measurements)
Number of subjects: 750
Study 34538275 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-guided heparinization
Number of subjects: 750
Study 36017827 — intervention group
Group type: EXPERIMENTAL
Intervention: RID-TDS (twice weekly)
Number of subjects: 57
Study 36017827 — intervention group
Group type: COMPARATOR
Intervention: Exelon® (once daily)
Number of subjects: 57
Study 32595083 — intervention group
Group type: EXPERIMENTAL
Intervention: Family mealtime communication
Number of subjects: 280
Study 32595083 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-parent household
Number of subjects: 280
Study 32206785 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 0
Study 32206785 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolyl-hydroxylase domain (PHD) inhibitors
Number of subjects: 0
Study 33148203 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron
Number of subjects: 484
Study 33148203 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled trial of first-line intravenous iron
Number of subjects: 484
Study 35179521 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed orthoses
Number of subjects: 13
Study 35179521 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditionally made orthoses
Number of subjects: 13
Study 35179521 — intervention group
Group type: COMPARATOR
Intervention: No orthoses
Number of subjects: 13
Study 33630638 — intervention group
Group type: EXPERIMENTAL
Intervention: Similar Age Same Gender (SASG) exercise program
Number of subjects: 483
Study 33630638 — intervention group
Group type: EXPERIMENTAL
Intervention: Similar Age Mixed Gender (SAMG) exercise program
Number of subjects: 483
Study 33630638 — intervention group
Group type: COMPARATOR
Intervention: Standard Mixed Age Mixed Gender (MAMG) exercise program
Number of subjects: 483
Study 35306340 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized assay targeting tumour‐informed mutations
Number of subjects: 60
Study 35306340 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal panel of genes frequently mutated in colorectal cancer (CRC)
Number of subjects: 60
Study 35306340 — intervention group
Group type: EXPERIMENTAL
Intervention: Low depth sequencing for copy number alterations (CNAs)
Number of subjects: 60
Study 32065760 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP
Number of subjects: 0
Study 32065760 — intervention group
Group type: EXPERIMENTAL
Intervention: NT‐proBNP
Number of subjects: 0
Study 32065760 — intervention group
Group type: EXPERIMENTAL
Intervention: NT‐proBNP to BNP ratio
Number of subjects: 0
Study 33924598 — intervention group
Group type: EXPERIMENTAL
Intervention: B-E (Breakfast and Exercise)
Number of subjects: 82
Study 32450733 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 70
Study 32450733 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 70
Study 32450733 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of propofol and desflurane
Number of subjects: 70
Study 32450733 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil infusion
Number of subjects: 70
Study 32450733 — intervention group
Group type: COMPARATOR
Intervention: Bilateral vs unilateral surgery
Number of subjects: 70
Study 34989797 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3‐PL/FFA (4 g/d)
Number of subjects: 520
Study 34989797 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cornstarch)
Number of subjects: 520
Study 33561968 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacto-ovo-vegetarian diet (VD; 65 g/day protein)
Number of subjects: 10
Study 33561968 — intervention group
Group type: COMPARATOR
Intervention: Western-type diet (WD; 95 g/day protein)
Number of subjects: 10
Study 33561968 — intervention group
Group type: COMPARATOR
Intervention: Mixed diet (MD; 65 g/day protein)
Number of subjects: 10
Study 35255077 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia
Number of subjects: 297
Study 35255077 — intervention group
Group type: COMPARATOR
Intervention: Spinal Anesthesia
Number of subjects: 297
Study 34105880 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-borne RME appliance (hyrax)
Number of subjects: 32
Study 34105880 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-bone-borne RME appliance (hybrid hyrax)
Number of subjects: 32
Study 34105880 — intervention group
Group type: COMPARATOR
Intervention: Comparison between hyrax and hybrid hyrax
Number of subjects: 32
Study 35632583 — intervention group
Group type: EXPERIMENTAL
Intervention: Advertising campaign for influenza vaccination using posters and pamphlets in GP waiting rooms
Number of subjects: 23024
Study 35632583 — intervention group
Group type: COMPARATOR
Intervention: Control group of the initial RCT
Number of subjects: 23024
Study 33198644 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide cases
Number of subjects: 242
Study 33198644 — intervention group
Group type: COMPARATOR
Intervention: Matched living controls
Number of subjects: 242
Study 33198644 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 242
Study 35495371 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive pressure (PEEP level of 5 CmH2o)
Number of subjects: 100
Study 35495371 — intervention group
Group type: COMPARATOR
Intervention: Negative pressure (suction pressure of 100 mmHg)
Number of subjects: 100
Study 35495371 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive pressure
Number of subjects: 100
Study 35495371 — intervention group
Group type: COMPARATOR
Intervention: Negative pressure
Number of subjects: 100
Study 32081514 — intervention group
Group type: EXPERIMENTAL
Intervention: International Society for Stem Cell Research booklet
Number of subjects: 112
Study 32081514 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem Cell Network video
Number of subjects: 112
Study 32081514 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 112
Study 35681696 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised risk estimate calculated using the CanRisk risk prediction tool.
Number of subjects: 0
Study 35681696 — intervention group
Group type: COMPARATOR
Intervention: Conventional cancer risk estimates as per routine clinical practice.
Number of subjects: 0
Study 35681696 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised risk estimate.
Number of subjects: 0
Study 32056186 — intervention group
Group type: EXPERIMENTAL
Intervention: Definitive chemoradiotherapy
Number of subjects: 0
Study 32056186 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity modulated radiotherapy
Number of subjects: 0
Study 33506875 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous tocilizumab (s.c.-TCZ) 162 mg/dose administered weekly or every 2 weeks for sJIA and every 2 or 3 weeks for pJIA based on body weight.
Number of subjects: 103
Study 33506875 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous tocilizumab (s.c.-TCZ)
Number of subjects: 103
Study 32366293 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD) for 5 weeks during acute care
Number of subjects: 60
Study 32366293 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital diet (SD)
Number of subjects: 60